Sioutas from the Department of Neurosurgery at Virginia Commonwealth University explored their therapeutic role in IIH
Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not
Moreover, as previously mentioned, another study by Sun et al
Megan DeChatelets, MS, RDN, CDN, IFNCP, a Registered Dietitian Nutritionist licensed in New York and Texas
In collaboration with Carelon Research , our study on glucagon-like peptide-1 receptor agonists (GLP-1-RAs) exemplifies our commitment to ensuring that high-profile treatments deliver on their promise of efficacy while maintaining patient safety
Similarly ALA, the primary indication for benfotiamine is symptomatic DPN, which includes not only neuropathic pain but also other unpleasant symptoms